Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Gastroenterology

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2017.05.056PMID 28601482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The learning curve, interobserver, and intraobserver agreement of endoscopic confocal laser endomicroscopy in the assessment of mucosal barrier defects.

  2016cited by this paper
• IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being

  2016cited by this paper
• Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials.

  2015cited by this paper
• Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome.

  2014cited by this paper
• Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low‐dose aspirin

  2014cited by this paper
• Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.

  2014cited by this paper
• Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation

  2013cited by this paper
• 205 Intestinal Barrier Dysfunction Measured With Confocal Endomicroscopy in Macroscopically Normal Mucosa Can Predict Requirement for Treatment Escalation

  2013cited by this paper
• The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

  2013cited by this paper
• Intestinal permeability defects: is it time to treat?

  2013cited by this paper
• Acute experimental stress evokes a differential gender‐determined increase in human intestinal macromolecular permeability

  2012cited by this paper
• Intestinal mucosal leakage is detected using in vivo confocal endomicroscopy in macroscopically-n

  2012cited by this paper
• Status of confocal laser endomicroscopy in gastrointestinal disease.

  2012cited by this paper
• Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

  2012cited by this paper
• Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.

  2012cited by this paper
• Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier

  2012cited by this paper
• Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

  2012cited by this paper
• Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease

  2011cited by this paper
• Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation

  2011cited by this paper
• Mind The Gaps: Confocal Endomicroscopy Showed Increased Density of Small Bowel Epithelial Gaps in Inflammatory Bowel Disease

  2011cited by this paper
• Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI

  2010cited by this paper
• Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

  2010cited by this paper
• Endoscopy: Fluorescein contrast in confocal laser endomicroscopy

  2010cited by this paper
• Intestinal barrier dysfunction in inflammatory bowel diseases.

  2009cited by this paper
• In vivo confocal endomicroscopy in the diagnosis and evaluation of celiac disease.

  2008cited by this paper
• Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

  2008cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  2006cited by this paper
• Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

  2002cited by this paper
• Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

  2002cited by this paper
• A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

  2000cited by this paper
• Self-reported food intolerance in chronic inflammatory bowel disease.

  1997cited by this paper

• F-actin dynamics couples sphingolipid metabolism to epithelial barrier integrity in chronic colitis

  2026cites this paper
• Betanin ameliorates dextran sulfate sodium-induced colitis in mice by modulating tight junction protein expression.

  2026cites this paper
• A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity

  2026cites this paper
• Engineering probiotics for inflammatory bowel disease: Strategies and perspectives

  2025cites this paper
• Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBD.

  2025cites this paper
• Chlorpyrifos Inhibits Intestinal Stem Cell Proliferation and Differentiation at the Acceptable Daily Intake and Disrupts Immune Responses at High Doses.

  2025cites this paper
• Small molecule drug absorption in inflammatory bowel disease and current implementation in physiologically- based pharmacokinetic models.

  2025cites this paper
• Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Pathophysiology to Precision Therapeutics.

  2025cites this paper
• The Impact of Imidacloprid in Dietary Residues on Intestinal Damage and the Increased Risk of Enterotoxigenic Escherichia coli Infection

  2025cites this paper
• Discordance between patients’ perception and endoscopic assessment of disease activity in ulcerative colitis

  2025cites this paper
• Research progress on colonization of probiotics

  2025cites this paper
• Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission.

  2025cites this paper
• Novel outcomes in inflammatory bowel disease

  2025cites this paper
• The preclinical discovery and development of upadacitinib for the treatment of Crohn’s disease

  2025cites this paper
• Morbus Crohn, Reizdarmsyndrom und chronische Müdigkeit: Die Bedeutung von Kommunikation und Symptommanagement – ein Fallbericht

  2025cites this paper
• Proteomic Profile of Human Colon Organoids: Effects of a multi-mineral intervention alone and in the presence of pro-Inflammatory and anti-inflammatory treatments

  2025cites this paper
• Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation

  2025cites this paper
• Integrated Stress Response and Necroptosis Drive Epithelial Dysfunction in Crohn’s Disease: Repurposing Cancer drugs for Permeability Barrier Healing

  2025cites this paper
• Osteopontin in Chronic Inflammatory Diseases: Mechanisms, Biomarker Potential, and Therapeutic Strategies

  2025cites this paper
• Parishin from Gastrodia elata ameliorates DSS induced colitis and anxiety-like behavior in mice by regulating intestinal barrier function and microviota-gut-brain axis.

  2025cites this paper
• Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis.

  2025cites this paper
• An Inhibitor of Death-Associated Protein Kinase 3 (DAPK3) Disrupts Hippo Signaling and Intestinal Epithelial Regeneration in Murine DSS-Induced Colitis.

  2025cites this paper
• Crohn’s disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management—a case report

  2025cites this paper
• Gentiopicroside improves DSS-induced ulcerative colitis and secondary liver injury in mice by enhancing the intestinal barrier and regulating the gut microbiome

  2025cites this paper
• Naringenin Alleviates the Autophagy-Associated AMPK-Akt/mTOR Pathway to Regulate Inflammation and Barrier Function, Decreasing DSS-Induced Intestinal Fibrosis

  2025cites this paper
• An enhanced bioactive chitosan-modified microemulsion for mucosal healing of ulcerative colitis.

  2024cites this paper
• Immunosenescence: A new direction in anti-aging research.

  2024cites this paper
• The landscape of new therapeutic opportunities for IBD.

  2024cites this paper
• Kynurenine Attenuates Ulcerative Colitis Mediated by the Aryl Hydrocarbon Receptor.

  2024cites this paper
• Protocatechuic acid/sodium alginate multilayer coating induced by metal ion enhanced the ulcerative colitis alleviations of Lactiplantibacillus plantarum.

  2024cites this paper
• From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease.

  2024cites this paper
• The value of assessing deep disease healing by probe‐based confocal laser endomicroscopy and histology for long‐term prognosis of ulcerative colitis

  2024cites this paper
• Calcitonin gene-related peptide promotes epithelial reparative and anti-colitic functions of IL-4 educated human macrophages.

  2024cites this paper
• Protective role of polysaccharide from the roots of Millettia speciosa Champ in mice with ulcerative colitis induced by dextran sulphate sodium.

  2024cites this paper
• Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways

  2024cites this paper
• Qin-Yu-Qing-Chang decoction reshapes colonic metabolism by activating PPAR-γ signaling to inhibit facultative anaerobes against DSS-induced colitis

  2024cites this paper
• The Role of Claudins in the Pathogenesis of Dextran Sulfate Sodium-Induced Experimental Colitis: The Effects of Nobiletin

  2024cites this paper
• Artificial mucus layer formed in response to ROS for the oral treatment of inflammatory bowel disease.

  2024cites this paper
• Modulation of gut microbiota on intestinal permeability: A novel strategy for treating gastrointestinal related diseases.

  2024cites this paper
• Challenges in IBD Research 2024: Precision Medicine.

  2024cites this paper
• Tannic Acid and Zinc Ion Coordination of Nanase for the Treatment of Inflammatory Bowel Disease by Promoting Mucosal Repair and Removing Reactive Oxygen and Nitrogen Species.

  2024cites this paper
• Intestinal Colonized Silkworm Chrysalis-Like Probiotic Composites for Multi-Crossed Comprehensive Synergistic Therapy of Inflammatory Bowel Disease.

  2024cites this paper
• Exploring the Interconnections of Functional Gut Disorders and Inflammatory Bowel Disease: A Narrative Review Article

  2024cites this paper
• Modified Zhenwu Decoction improved intestinal barrier function of experimental colitis through activation of sGC-mediated cGMP/PKG signaling.

  2024cites this paper
• Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients

  2024cites this paper
• Enteric glia as friends and foes of the intestinal epithelial barrier function

  2024cites this paper
• First-in-Human Assessment of Gut Permeability in Crohn’s Disease Patients Using Fluorophore Technology

  2024cites this paper
• F.O.R.W.A.R.D: A Data-Driven Framework for Network-Based Target Prioritization in Drug Discovery

  2024cites this paper
• Changes in Digestive Health, Satiety and Overall Well-Being after 14 Days of a Multi-Functional GI Primer Supplement

  2024cites this paper
• Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.

  2024cites this paper
• Paeoniflorin ameliorates chronic colitis via the DR3 signaling pathway in group 3 innate lymphoid cells

  2024cites this paper
• Effects of black raspberry, blueberry, and blackberry volatile extracts on intestinal barrier dysfunction and inflammation in a Caco-2/RAW264.7 cells co-culture model

  2024cites this paper
• Reply to van Gils et al.

  2024cites this paper
• Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling.

  2024cites this paper
• Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel disease

  2024cites this paper
• Angelicone Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota

  2024cites this paper
• Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device.

  2024cites this paper
• ПРОНИЦАЕМОСТЬ ЭПИТЕЛИАЛЬНОГО БАРЬЕРА КИШКИ: КРИТЕРИИ ОЦЕНКИ, РОЛЬ В ПАТОГЕНЕЗЕ ЦЕЛИАКИИ

  2024cites this paper
• Gut-bacteria derived membrane vesicles and host metabolic health: a narrative review

  2024cites this paper
• Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: A Pilot Trial (AMBIC)

  2024cites this paper
• Endoscopic indigo carmine spraying for evaluation of intestinal mucosal permeability: Prospective pilot study

  2024cites this paper
• Polyphenols-rich Portulaca oleracea L. (purslane) alleviates ulcerative colitis through restiring the intestinal barrier, gut microbiota and metabolites.

  2024cites this paper
• Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial.

  2024cites this paper
• Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD

  2024cites this paper
• Association of environmental tobacco smoke exposure with chronic constipation: a nationwide survey (NHANES 2005–2010)

  2023cites this paper
• Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus

  2023cites this paper
• Propionibacterium freudenreichii CIRM-BIA 129 mitigates colitis through S layer protein B-dependent epithelial strengthening.

  2023cites this paper
• Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis

  2023cites this paper
• The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways

  2023cites this paper
• Human organoids are superior to cell culture models for intestinal barrier research

  2023cites this paper
• Disease Severity Impairs Generation of Intestinal Organoid Cultures From Inflammatory Bowel Disease Patients.

  2023cites this paper
• Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

  2023cites this paper
• Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances.

  2023cites this paper
• A spotlight on intestinal permeability and inflammatory bowel diseases

  2023cites this paper
• Salivary Alterations of Myeloperoxidase in Patients with Systemic Diseases: A Systematic Review

  2023cites this paper
• Role of ultra‐high definition endoscopy (endomicroscopy and endocytoscopy) and real‐time histologic examination in inflammatory bowel disease: Scoping review

  2023cites this paper
• Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases

  2023cites this paper
• Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing

  2023cites this paper
• Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease

  2023cites this paper
• TLR5 Signaling in the Regulation of Intestinal Mucosal Immunity

  2023influential citation
• Dietary 5-demethylnobiletin attenuated dextran sulfate sodium-induced colitis in mice by inhibiting immune response and regulating gut microbiota.

  2023cites this paper
• The Fecal Microbiome in Quiescent Crohns Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers

  2023cites this paper
• 25-Hydroxycholesterol in health and diseases

  2023cites this paper
• Novelties on non-invasive biomarkers for the assessment of intestinal permeability and gut barrier integrity in patients with inflammatory bowel diseases.

  2023cites this paper
• Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease

  2023cites this paper
• Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies

  2023cites this paper
• Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway.

  2023cites this paper
• Selective JAK1 inhibitors for the treatment of inflammatory bowel disease.

  2023cites this paper
• Peripheral neural mechanism of visceral pain and acupoint sensitization in 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis model mice.

  2023cites this paper
• Intestinal barrier in inflammatory bowel disease: A bibliometric and knowledge-map analysis

  2023cites this paper
• Egg Yolk Lipids Alleviated Dextran Sulfate Sodium-Induced Colitis by Inhibiting NLRP3 Inflammasome and Regulating Gut Microbiota.

  2023cites this paper
• Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy

  2023cites this paper
• Insights of Endocytosis Signaling in Health and Disease

  2023cites this paper
• A multi-mineral intervention to counter pro-inflammatory activity and to improve the barrier in human colon organoids

  2023cites this paper
• Moutai Distiller's grains Polyphenol extracts and rutin alleviate DSS-induced colitis in mice: Modulation of gut microbiota and intestinal barrier function （R2）

  2023cites this paper
• Taraxacum coreanum Nakai extract attenuates lipopolysaccharide-induced inflammatory responses and intestinal barrier dysfunction in Caco-2 cells.

  2023cites this paper
• Lactobacillus rhamnosus CY12 Enhances Intestinal Barrier Function by Regulating Tight Junction Protein Expression, Oxidative Stress, and Inflammation Response in Lipopolysaccharide-Induced Caco-2 Cells

  2022influential citation
• Minocycline prevents the development of key features of inflammation and pain in DSS-induced colitis in mice.

  2022cites this paper
• Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis?

  2022cites this paper
• Concurrent functional gastrointestinal disorders in patients with inflammatory bowel disease

  2022cites this paper